TO DEVELOP ARP-HPLC ASSAY METHOD FOR SIMULTANEOUS ESTIMATION OF ESCITALOPRAM&CLONAZEPAM FORIT’S QUANTIFICATION IN FINISHED DOSAGE FORM

Authors

  • Deven Mehta M.Pharm student at SVKM’s NMiMS, Shirpur, Maharastra
  • G. S. Chhabra Dept. of Pharmaceutical Chemistry SVKM’s NMiMS, Shirpur, Maharastra
  • Sanjay Pednekar Senior Manager at Medley Pharmaceutical Ltd. , Maharastra

Keywords:

Escitalopram, Clonazepam, RP-HPLC,Validation, ICH Guidelines

Abstract

A Simple, efficient and reproducible reverse phase high performance liquid chromatographic method was developed and validated for the Simultaneous determination of Escitalopram oxalate and Clonazepam in combined dosage form.The process was carried out on aInertsil C18 ODS 3V, 15 cm X 4.6 mm, 5µm or equivalent column. The flow rate was 1ml/min and eluent was monitored by absorbance at 254 nm using a mixture of Methanol and Buffer (pH 7.0) in the ratio of 55:45 (v/v). The retention times of Escitalopram and Clonazepam was found to be 17.3 and 10.02 min respectively. Calibration plots were linear in the concentration range of 80-120ppm and 8-12ppm for Escitalopram and clonazepam respectively. All the analytical validation parameters were determined and foundto be within the limit as per ICH guidelines, which indicates the validity of the method. The developed method is also found to be precise, accurate, specific, robust and rapid for the simultaneous determination of Escitalopram oxalate and Clonazepam in tablet dosage forms.

Downloads

Download data is not yet available.

Published

2014-01-01

How to Cite

Mehta, D., Chhabra, G. S., & Pednekar, S. (2014). TO DEVELOP ARP-HPLC ASSAY METHOD FOR SIMULTANEOUS ESTIMATION OF ESCITALOPRAM&CLONAZEPAM FORIT’S QUANTIFICATION IN FINISHED DOSAGE FORM. Asian Journal of Pharmaceutical Research and Development, 2(1), 40–45. Retrieved from https://ajprd.com/index.php/journal/article/view/233

Issue

Volume 2nd Issue 1st Jan-Feb 2014

Section

Research Articles

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).